Abstract
This study sought to identify runner characteristics or symptoms that could distinguish those finishers developing exercise-associated hyponatremia (EAH) from those not developing EAH in a 161-km ultramarathon. Of 310 finishers, 207 (67%) underwent postrace blood studies. Twelve (6%) finishers had EAH (blood sodium range 131–134 mmol/L). Experience at 161-km ultramarathons was lower (p = 0.01) and blood creatine kinase (CK) concentration was higher (p = 0.04) among those with EAH than those not developing EAH. Blood sodium and CK concentration were negatively correlated (p = 0.0015, r = −0.22). There were no group differences in age, sex, regular running experience, weekly training distance, use of sodium supplements during training, immediately postrace sodium palatability and thirst ratings, body mass change, urination frequency, nonsteroidal anti-inflammatory drugs (NSAIDs) use, and various symptoms experienced during the race. These findings indicate that a clinical suspicion and measurement of blood sodium concentration remain the only viable means for determining when an ultramarathon runner has EAH.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
